Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioMarker Strategies LLC" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about BioMarker Strategies LLC for you to read. Along with our medical data and news we also list BioMarker Strategies LLC Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMarker Strategies LLC Companies for you to search.
Since tumors often have unique defects in the DNA damage response (DDR) pathway, identifying the molecular mechanisms that underlie how cells repair various DNA lesions is critical to selecting the appropriate clinical treatments. Inhibitors to poly-(ADP-ribose) polymerase (PARP) are examples of drugs that successfully exploit the DDR pathway and have become an effective cancer therapy […] T...
Modernizing clinical trials is an agency wide priority. As more diseases are being redefined based on genomic subtype, researchers have more novel targets and more opportunities to precisely modulate or even repair the basic biological drivers of illness. Precision guided medicines can demonstrate strong efficacy signals in early clinical trials, including in trials where small …
Dr Deborah I. Friedman suggests strategies for arriving at a correct diagnosis when taking a headache history. American Headache Society and Medscape
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 12:40 The issuer is solely responsible for the content of this announcement. Press release U.S. Representatives Payne and Marchant Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based t...
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 15.03.2019 / 12:40 The issuer is solely responsible for the content of this announcement. U.S. Representatives Payne, Marchant, and Sewell Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests ...
Vycellix™, Inc. today announced that the Company, founded by leading medical researchers at Sweden’s world renowned Karolinska Institutet, will present at the Innate Killer Summit 2019 to be held in San Diego, March 20-21. On Wednesday, March 20th at 4:20pm PT, Vycellix’s founding CEO, Evren Alici, M.D., Ph.D. will present the session titled...
A new final guidance by the European Medicines Agency outlines broad principles and strategies that regulatory assessors can ...
FRIDAY, March 15, 2019 -- There may be a small benefit to labor induction in low-risk woman at 41 weeks versus expectant management, though the chances of a good perinatal outcome are high with both strategies, according to a study published online...
ArQule, Inc. (Nasdaq: ARQL) today announced that Robert Weiskopf, Senior Vice President, Chief Financial Officer and Treasurer, has decided to retire effective March 29 of this year. In conjunction with Mr. Weiskopf’s departure, ArQule is naming Marc Schegerin, MD as Chief Financial Officer and Head of Strategy, effective as of Mr. Weiskopf’s retiremen...
The Critical Path Institute's (C-Path) Predictive Safety Testing Consortium (PSTC) today announced availability of the User's Guide: Kidney Safety Composite Measure Biomarker for Use in Clinical Development.
Globally, the burden of neurological disorders, as measured by the absolute number of DALYs, continues to increase. As populations are growing and ageing, and the prevalence of major disabling neurological disorders steeply increases with age, governments will face increasing demand for treatment, rehabilitation, and support services for neurological disorders. The scarcity of established modifiab...
(Siberian Federal University) A group of researchers is in the process of developing a highly sensitive biosensor designed to detect toxic substances using bioluminescent inhibitory analysis as well as to monitor a biomarker for indicating stress and cancer, namely heat shock proteins 90 (Hsp90).
(George Washington University) A team at the George Washington University Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of pancreatic cancer, as well as ovarian and breast cancers.
New therapeutic approaches for treating patients with earlier-stage melanoma who face a higher risk of recurrence are among the features of recently updated consensus guidelines from the Society for Immunotherapy of Cancer.
Both technologies address unmet needs for patients with celiac disease ImmunogenX is pleased to announce the initiation of a Phase 2 clinical trial (named Celiac Shield™), sponsored by the National Institutes of Health’s (NIH) National Center for Complementary and Integrative Health (NCCIH), to be conducted at the Mayo Clinic in Rochester, MN. The trial ...
New Front-Line Data Presented at Multidisciplinary Thoracic Cancers Symposium Biodesix® today presented new data demonstrating that the VeriStrat® test is predictive of outcomes for patients with non-small
SAN DIEGO, March 13, 2019 /PRNewswire/ — Epic Sciences, Inc. (Epic) today announced the publication of results from a multicenter prospective trial validating the biomarker AR-V7 (androgen receptor splice variant-7) as a predictor of resistance to anti-androgen therapy in men with metastatic castration-resistant prostate cancer (mCRPC). Data from the PROPHECY trial, published in the Journal ...
This session will feature video segments about a family dealing with the heartbreak of opioid addiction Pharmacy Times Continuing Education™ (PTCE), a leader in continuing education for retail, health-system, managed care and specialty pharmacists, will host a special session during its ninth annual Directions in Pharmacy® continuing education confe...
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: New enzyme boosts ‘CRISPR toolbox’ for disease detection .Mammoth Biosciences is harnessing CRISPR to create diagnostic tools that can detect any biomarker containing DNA or RNA, with the … Continue reading →
Similar patient outcomes were seen with restrictive and liberal transfusion strategies.
SCC Soft Computer (SCC) announced Specialist Diagnostic Services Pty Ltd (SDS Pathology), as a new client. SDS Pathology, the pathology division of Australian listed healthcare provider, Healius Limited, will be replacing their current system, Ultra (Triple G) with SCC’s Laboratory and Genetics Information Management Systems —including SCC’s...
Given the poor prognosis of pancreatic cancer and the steady stream of negative phase III trials, clinicians are facing an uphill battle in the treatment of patients with metastatic pancreatic cancer.
FDA issues statement on new strategies to modernize clinical trials to advance precision medicine, patient protections and more efficient product development
The immunotherapy BCG is in short supply in the United States. The American Urological Association and other groups have responded with a set of treatment strategies for clinicians, but problems are piling up. Medscape Medical News
Netsmart announced today that Wendy Hill has been named the company’s first chief people officer (CPO). Hill will lead this new function that includes the human resources and associate development organization for the Kansas-headquartered healthcare IT provider. To accelerate the company’s focus on developing a people-first culture and ...